OMER Q1 2025 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$835M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$35M

Net Income

-$33M

EPS (Diluted)

$-0.58

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$36M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$235M

Total Liabilities

$449M

Stockholders' Equity

-$214M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$204,000	+100.0%
Operating Income	-$35M	-$39M	+10.4%
Net Income	-$33M	-$37M	+10.0%